1. Home
  2. MRSN vs OESX Comparison

MRSN vs OESX Comparison

Compare MRSN & OESX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRSN
  • OESX
  • Stock Information
  • Founded
  • MRSN 2001
  • OESX 1996
  • Country
  • MRSN United States
  • OESX United States
  • Employees
  • MRSN N/A
  • OESX N/A
  • Industry
  • MRSN Biotechnology: Pharmaceutical Preparations
  • OESX Building Products
  • Sector
  • MRSN Health Care
  • OESX Consumer Discretionary
  • Exchange
  • MRSN Nasdaq
  • OESX Nasdaq
  • Market Cap
  • MRSN 37.0M
  • OESX 32.5M
  • IPO Year
  • MRSN 2017
  • OESX 2007
  • Fundamental
  • Price
  • MRSN $8.07
  • OESX $8.00
  • Analyst Decision
  • MRSN Strong Buy
  • OESX Strong Buy
  • Analyst Count
  • MRSN 3
  • OESX 2
  • Target Price
  • MRSN $33.00
  • OESX $17.50
  • AVG Volume (30 Days)
  • MRSN 41.5K
  • OESX 15.4K
  • Earning Date
  • MRSN 11-12-2025
  • OESX 11-05-2025
  • Dividend Yield
  • MRSN N/A
  • OESX N/A
  • EPS Growth
  • MRSN N/A
  • OESX N/A
  • EPS
  • MRSN N/A
  • OESX N/A
  • Revenue
  • MRSN $34,769,000.00
  • OESX $79,389,000.00
  • Revenue This Year
  • MRSN N/A
  • OESX $6.70
  • Revenue Next Year
  • MRSN N/A
  • OESX $13.43
  • P/E Ratio
  • MRSN N/A
  • OESX N/A
  • Revenue Growth
  • MRSN 16.14
  • OESX N/A
  • 52 Week Low
  • MRSN $5.21
  • OESX $5.50
  • 52 Week High
  • MRSN $70.75
  • OESX $10.35
  • Technical
  • Relative Strength Index (RSI)
  • MRSN 61.29
  • OESX 52.89
  • Support Level
  • MRSN $7.63
  • OESX $7.92
  • Resistance Level
  • MRSN $8.35
  • OESX $8.40
  • Average True Range (ATR)
  • MRSN 0.39
  • OESX 0.54
  • MACD
  • MRSN 0.01
  • OESX -0.33
  • Stochastic Oscillator
  • MRSN 72.97
  • OESX 8.10

About MRSN Mersana Therapeutics Inc.

Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.

About OESX Orion Energy Systems Inc.

Orion Energy Systems Inc is engaged in light-emitting diode lighting systems, wireless Internet of Things-enabled control solutions, project engineering, energy project management design, maintenance services, and turnkey electric vehicle charging stations and related installation services to commercial and industrial businesses, and federal and local governments, predominantly in North America. The group has three segments: the Orion lighting segment, the Orion maintenance segment, and the Orion electric vehicle charging segment. It generates the majority of its revenue from the Orion lighting segment, which develops and sells lighting products and provides construction and engineering services for Orion's commercial lighting and energy management systems.

Share on Social Networks: